Rise Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Hold |
448
| – | – | 0.01% | 306 |
|
|
2025
Q1 | $32.5K | Sell |
448
-36
| -7% | -$2.61K | 0.01% | 308 |
|
|
2024
Q4 | $35.8K | Buy |
484
+7
| +1% | +$518 | 0.02% | 321 |
|
|
2024
Q3 | $31.5K | Hold |
477
| – | – | 0.02% | 396 |
|
|
2024
Q2 | $44.1K | Hold |
477
| – | – | 0.02% | 252 |
|
|
2024
Q1 | $45.6K | Buy |
477
+265
| +125% | +$25.3K | 0.02% | 246 |
|
|
2023
Q4 | $16.2K | Hold |
212
| – | – | 0.01% | 268 |
|
|
2023
Q3 | $14.7K | Buy |
212
+92
| +77% | +$6.37K | 0.01% | 266 |
|
|
2023
Q2 | $11.3K | Hold |
120
| – | – | 0.01% | 323 |
|
|
2023
Q1 | $9.93K | Hold |
120
| – | – | 0.01% | 361 |
|
|
2022
Q4 | $8.95K | Hold |
120
| – | – | 0.01% | 365 |
|
|
2022
Q3 | $10K | Buy |
+120
| New | +$10K | 0.01% | 334 |
|